Mechanism of therapeutic effect of high-dose intravenous immunoglobulin. Attenuation of acute, complement-dependent immune damage in a guinea pig model (Q34581633)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Mechanism of therapeutic effect of high-dose intravenous immunoglobulin. Attenuation of acute, complement-dependent immune damage in a guinea pig model	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

Mechanism of therapeutic effect of high-dose intravenous immunoglobulin. Attenuation of acute, complement-dependent immune damage in a guinea pig model (English)

1 reference

Europe PubMed Central

3 August 2017

0 references

author name string

Basta M

1

1 reference

Europe PubMed Central

3 August 2017

Kirshbom P

2

1 reference

Europe PubMed Central

3 August 2017

Frank MM

3

1 reference

Europe PubMed Central

3 August 2017

Fries LF

4

1 reference

Europe PubMed Central

3 August 2017

language of work or name

0 references

publication date

1 December 1989

1 reference

Europe PubMed Central

3 August 2017

Journal of Clinical Investigation

1 reference

Europe PubMed Central

3 August 2017

84

1 reference

Europe PubMed Central

3 August 2017

6

1 reference

Europe PubMed Central

3 August 2017

1974-1981

1 reference

Europe PubMed Central

3 August 2017

The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=304080

7 July 2018

Classical complement pathway activation by antipneumococcal antibodies leads to covalent binding of C3b to antibody molecules

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=304080

7 July 2018

C3b covalently bound to IgG demonstrates a reduced rate of inactivation by factors H and I

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=304080

7 July 2018

High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=304080

7 July 2018

The Relative Efficacies of 7S and 19S Forssman Antibody in Producing Lesions in the Guinea Pig

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=304080

7 July 2018

Heterophile antibodies and tissue injury. 3. A role for platelets in the development of lethal vascular injury during Forssman shock in guinea pigs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=304080

7 July 2018

Complement-mediated tissue damage: contribution of the classical and alternate complement pathways in the Forssman reaction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=304080

7 July 2018

Intravenous and standard immune serum globulin preparations interfere with uptake of 125I-C3 onto sensitized erythrocytes and inhibit hemolytic complement activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=304080

7 July 2018

Intravenous immunoglobulins as therapeutic agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=304080

7 July 2018

Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=304080

7 July 2018

High-dose intravenous immunoglobulin modifies complement-mediated in vivo clearance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=304080

7 July 2018

A study of the cellular distribution of Forssman antigen in various species

1 reference

https://pubmed.ncbi.nlm.nih.gov/2687331

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunopharmacological approach to Forssman shock

1 reference

https://pubmed.ncbi.nlm.nih.gov/2687331

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Large scale isolation of functionally active components of the human complement system

1 reference

https://pubmed.ncbi.nlm.nih.gov/2687331

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Generation of low m.w., C3-bearing immunoglobulin in human serum

1 reference

https://pubmed.ncbi.nlm.nih.gov/2687331

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interaction of C3 and C3b with immunoglobulin G

1 reference

https://pubmed.ncbi.nlm.nih.gov/2687331

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin

1 reference

https://pubmed.ncbi.nlm.nih.gov/2687331

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1172/JCI114387

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34581633&oldid=1966776039"